Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
批准号:
10044350
负责人:
CAROLE A OSKERITZIAN
金额:
$20.9万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2022-06-30
关键词:
AddressAgeAmericanApcMin/+ miceAppearanceAzoxymethaneBiologicalBlood VesselsBrightfield MicroscopyCancer ControlCarcinogensCell physiologyCellsCellular biologyClinicClinicalColonColonic PolypsColonoscopyColorectal CancerComputer AssistedComputer softwareDNA analysisDataData AnalysesDescriptorDetectionDevelopmentDiagnosticDiffusion Magnetic Resonance ImagingDiseaseDistalDistantDoctor of MedicineEarly DiagnosisEndoscopyEnsureEquipmentEventExcisionFDA approvedFamily PracticeFecesFlexible fiberoptic sigmoidoscopyGenetic ModelsGoldHealthHomeostasisHumanHuman ResourcesImageImage AnalysisImmuneInterventionIntestinal PolyposisIntestinesLaboratoriesLesionLow incomeMalignant NeoplasmsMaster of Public HealthMeasuresMedicalMethodsMicroscopyModalityModelingMorbidity - disease rateMorphologyMusPatientsPerformancePhysiciansPilot ProjectsPolypsPopulationPre-Clinical ModelPrecancerous PolypPreventionPreventive MedicinePrimary Health CareProceduresProcessRetrievalSamplingScheduleSentinelSlideSpecificitySpecimenStainsStandardizationStructureSwabTechnologyTestingTissuesTrainingValidationWild Type Mouseadenomaadherence ratebasecancer geneticscancer preventioncarcinogenesisclinical practicecolorectal cancer preventioncolorectal cancer screeningcomplex data computer aided detectioncomputer data analysiscomputerizedcostcost effectivedesigndextran sulfate sodium induced colitisdigitalearly onsetequipment traininghuman tissueimaging modalityimprovedinnovationintestinal epitheliummast cellmedical schoolsminimally invasivemortalitymouse modelneoplasticpre-clinicalpreclinical studypremalignantpreservationpreventprimary care settingprismaprocedure costprofessorprogramsquantitative imagingrectalsample collectionscreeningtumor progressionuptakevalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Screening remains the key intervention for colorectal cancer (CRC) control and prevention as detection and
removal of premalignant lesions can prevent progression to cancer. Colonoscopy, the gold standard for CRC
screening, is an invasive and costly procedure resulting in low compliance in both the general and the under-
screened populations, including low-income and early-onset young patients. Feces-screening methods also
suffer low compliance rates. Affordable and minimally invasive approaches are urgently warranted to address
low screening rates and prevent CRC through early detection. We are proposing to explore the concept of field
effect in CRC or simultaneous occurrence of subtle alterations distal from precancerous polyps in the colon, in
an innovative way, to develop a new screening modality for CRC. Mast cells (MC) are innate immune cells
located close to the intestinal epithelium and blood vessels at homeostasis, whose accumulation is an
essential feature of intestinal polyposis in mice and of invasive intestinal lesions. We hypothesized that MC
might slough off in the colonic lumen upon precancerous transformation, but not in normal healthy cases, thus
being accessible by rectal swabbing, together with other cells. Combining our dual expertise in quantitative
imaging and mast cell (MC) biology, we surmise that swab-collected cells might be analyzed on microscopy
slides after processing and staining for MC using bright-field microscopy and image analysis software. Our
preliminary results using two preclinical models of CRC, the genetic ApcMin/+ mouse model and the
azoxymethane/dextran sulfate sodium-induced colitis leading to CRC, indicate the presence of swab MC in
polyp carrying but not in healthy polyp-free, inflamed polyp-free, cancer-free or wild type mice. To ensure
standardized sample analysis, we propose to develop a computational imaging method for swab MC detection
by integrating MC-restricted morphometric descriptors. Further biological and technical validations will be
performed. If confirm, our working hypothesis will be tested in a human pilot study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity
-
批准号:10650620
-
项目类别:
-
资助金额:$20.9万
-
财政年份:2023
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
-
批准号:10456820
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2020
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer
-
批准号:10174880
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2020
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
MicroRNAs in atopic dermatitis pathogenesis: a role for mast cell and sphingosine-1-phosphate?
-
批准号:9035633
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2016
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
48th Annual South Eastern Regional Lipid Conference (SERLC) Funding Support
-
批准号:8651999
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2013
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8295787
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8730283
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8681300
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Mast Cell S1P Receptor2 in the initiation and progression of chronic inflammation
-
批准号:8859955
-
项目类别:
-
资助金额:$34.53万
-
财政年份:2012
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7147486
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7628066
-
项目类别:
-
资助金额:$10.69万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7446651
-
项目类别:
-
资助金额:$10.44万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7257108
-
项目类别:
-
资助金额:$10.2万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
Sphingosine-1-Phosphate, A Novel Mediator of Human Skin Mass Cell Functions
-
批准号:7873014
-
项目类别:
-
资助金额:$10.94万
-
财政年份:2006
-
负责人:CAROLE A OSKERITZIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: